[Pubmed] Ocular myasthenia gravis

[RSS-Bot]

Vestn Oftalmol. 2024;140(4):86-91. doi: 10.17116/oftalma202414004186.

ABSTRACT

Myasthenia gravis is an autoimmune disease characterized by muscle weakness and pathological fatigue due to autoaggressive phenomena with the formation of antibodies directed against various structures of the neuromuscular synapse. In most patients, the disease begins with the involvement of extraocular muscles, presenting with symptoms such as intermittent ptosis of the upper eyelid and/or binocular diplopia. In 15% of cases, clinical manifestations are limited to impairment of the levator palpebrae superioris and extraocular muscles, characteristic of the ocular form of myasthenia gravis. Specialists often encounter challenges in diagnosing this form, as serological and electrophysiological studies may be uninformative, necessitating diagnosis based on patient history and clinical picture. This literature review outlines the key aspects of the pathogenesis, clinical manifestations, methods of diagnosis and treatment of ocular myasthenia gravis.

PMID:39254395 | DOI:10.17116/oftalma202414004186


Source: https://pubmed.ncbi.nlm.nih.gov/3925439 ... t9+e462414